Report post
23andMe's journey from a $6B valuation to penny stock status is a cautionary tale of high-risk speculation. CEO Anne Wojcicki's price hikes may be an attempt to revive the company, but investors should proceed with caution. The downfall of 23andMe highlights the importance of understanding business models and risks before investing.

The World's Leading Crypto Trading Platform

Get my welcome gifts